Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Assess Specific Kinds of Children Challenges for Neurologic Devices Study

24 de outubro de 2016 atualizado por: Carlos Pena, PhD, MS
The ASK CHILDREN study is intended to aid in future development of various neurologic devices (i.e. neuroprostheses). The ASK CHILDREN study seeks to use study information obtained to identify more efficient strategies in the evaluation and review of neuroprostheses regulated by the Agency.

Visão geral do estudo

Descrição detalhada

The ASK CHILDREN study is intended to aid in future development of various neurologic devices (i.e. neuroprostheses). The ASK CHILDREN study seeks to use study information obtained to identify more efficient strategies in the evaluation and review of neuroprostheses regulated by the Agency. Specific aims of the clinical study include: (1) Collecting qualitative and quantitative self-report clinical data (through interviews) from children undergoing treatment related to human factors, safety, usability, and adverse events in patients ages 7 to 15 years old implanted with a neuroprosthesis targeting the brain or spinal cord (at two 6 month intervals); and (2) Establish a science-based framework of recommendations based upon the data collected in the ASK CHILDREN Study to help develop more efficient strategies in evaluating pediatric neuroprostheses regulated by the Agency.

Tipo de estudo

Observacional

Inscrição (Real)

16

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

7 anos a 15 anos (Filho)

Aceita Voluntários Saudáveis

Não

Gêneros Elegíveis para o Estudo

Tudo

Método de amostragem

Amostra Não Probabilística

População do estudo

Primary Dystonia Criteria; Between ages 7 and 15 years of age, Approved medical device for Primary Dystonia, Neurologic device implanted within the past 12 months. Epilepsy Criteria; Between ages 12 and 15 years of age; Neurologic device implantation or surgical (in-hospital) adjustment within the past 12 months; Approved medical device. Pediatric Hydrocephalus Criteria; Between ages 7 and 15 years of age, Approved medical device, Neurologic shunt implantation or surgical (in-hospital) adjustment within the past 12 months. Spinal Cord Injury Criteria; Between ages 14 and 15 years of age, Approved medical device, Neurologic device implanted within the past 12 months. Deaf or Hearing Impaired Criteria; Between ages 7 and 15* years of age, Approved medical device.

Descrição

Primary Dystonia Inclusion Criteria

  • Between ages 7 and 15 years of age;
  • Implanted Medtronic Activa® Dystonia Therapy (approved or cleared by FDA for pediatric use).
  • Neurologic device implanted within the past 12 months;
  • Signed assent form document from the child
  • Signed permission form from the parent/guardian); and

Exclusion Criteria

  • Participation in another clinical investigation that could be jeopardized by participation in the current study;
  • Children with severe cognitive impairments (such as children with head injuries resulting in severe cognitive impairment) may be excluded because they may not be capable of self-reporting procedures.
  • Unable to comply with terms of the study

Epilepsy Inclusion Criteria

  • Between ages 12 and 15 years of age;
  • Neurologic device implantation or surgical (in-hospital) adjustment within the past 12 months;
  • NeuroCybernetic Prosthesis (NCP®) System (approved or cleared by FDA for pediatric use; the NCP® System is approved for children in ages 12 years and older).
  • Signed assent form document from the child; and
  • Signed permission form from the parent/guardian).

Epilepsy Exclusion Criteria

  • Participation in another clinical investigation that could be jeopardized by participation in the current study; and
  • Children with severe cognitive impairments (such as children with head injuries resulting in severe cognitive impairment) may be excluded because they may not be capable of self-reporting procedures.6
  • Unable to comply with terms of the study

Pediatric Hydrocephalus Inclusion Criteria

  • Between ages 7 and 15 years of age;
  • Implanted traditional or adjustable hydrocephalus shunt implant (approved or cleared by FDA for pediatric use).
  • Neurologic shunt implantation or surgical (in-hospital) adjustment within the past 12 months;
  • Signed assent form document from the child
  • Signed permission form from the parent/guardian)

Pediatric Hydrocephalus Exclusion Criteria

  • Participation in another clinical investigation that could be jeopardized by participation in the current study; and
  • Children with severe cognitive impairments (such as children with head injuries resulting in severe cognitive impairment) may be excluded because they may not be capable of self-reporting procedures.6
  • Unable to comply with terms of the study

Spinal Cord Injury Inclusion Criteria

  • Between ages 14 and 15 years of age;
  • Vocare® Bladder System implant (approved or cleared by FDA for pediatric use).
  • Neurologic device implanted within the past 12 months;
  • Signed assent form document from the child
  • Signed permission form from the parent/guardian); and

Spinal Cord Injury Exclusion Criteria

  • Participation in another clinical investigation that could be jeopardized by participation in the current study; and
  • Children with severe cognitive impairments (such as children with head injuries resulting in severe cognitive impairment) may be excluded because they may not be capable of self-reporting procedures.
  • Unable to comply with terms of the study

Deaf or Hearing Impaired Inclusion Criteria

  • Between ages 7 and 15* years of age;
  • Implanted cochlear implant (approved or cleared by FDA for pediatric use) with any device adjustment related to device performance or routine care of their current device within the past 12 months;
  • Signed assent form document from the child
  • Signed permission form from the parent/guardian); and

Deaf or Hearing Impaired Exclusion Criteria

  • Participation in another clinical investigation that could be jeopardized by participation in the current study; and
  • Children with severe cognitive impairments (such as children with head injuries resulting in severe cognitive impairment) may be excluded because they may not be capable of self-reporting procedures.
  • Unable to comply with terms of the study

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

Coortes e Intervenções

Grupo / Coorte
Shunt Implant
hydropcephalus cohort
Cochlear Implant
hearing impaired cohort
Spinal Cord Stiumulation
spinal cord injury cohort
Vagus Nerve Stimulation
epilepsy cohort
Deep Brain Stimulation
dystonia cohort

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Patrocinador

Investigadores

  • Investigador principal: Carlos L Pena, PhD, Food and Drug Administration (FDA)

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo

1 de março de 2009

Conclusão Primária (Real)

1 de dezembro de 2014

Conclusão do estudo (Real)

1 de dezembro de 2014

Datas de inscrição no estudo

Enviado pela primeira vez

26 de agosto de 2010

Enviado pela primeira vez que atendeu aos critérios de CQ

26 de agosto de 2010

Primeira postagem (Estimativa)

30 de agosto de 2010

Atualizações de registro de estudo

Última Atualização Postada (Estimativa)

25 de outubro de 2016

Última atualização enviada que atendeu aos critérios de controle de qualidade

24 de outubro de 2016

Última verificação

1 de outubro de 2016

Mais Informações

Termos relacionados a este estudo

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

NÃO

Descrição do plano IPD

Data sharing will occur via publication.

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever